BUZZ-BioCardia says FDA has cleared company to market its device, shares rise

Reuters
2024.08.28 22:08

股價上漲 92.73%，達到 4.24 美元，盤後交易後，美國 FDA 已批准 BioCardia 公司推出其設備，根據聯邦食品、藥品和化妝品法案的一般控制規定，一份文件顯示，Morph DNA 可導向導管產品旨在提供一條路徑，通過該路徑可以將醫療器械（如球囊擴張導管、導絲或其他治療設備）引入心臟的外周血管或心臟的心腔和冠狀血管。BCDA 股票今年以來下跌約 78%

BioCardia（BCDA.O）股價在收盤後上漲 92.73%，達到 4.24 美元

美國 FDA 已批准該公司營銷其設備，根據聯邦食品、藥品和化妝品法案的一般控制規定，一份文件顯示 Morph DNA 可操縱導管產品旨在提供一條路徑，通過該路徑可以將醫療器械（如球囊擴張導管、導絲或其他治療設備）引入心臟的外周血管或心臟的心腔和冠狀血管 - BCDA

今年以來股價下跌約 78%

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.